Resveratrol inhibits the proliferation of melanoma cells by modulating cell cycle

References

• Aronow ME, Topham AK, Singh AD. 2018. Uveal melanoma: 5-year update on incidence, treatment, and survival (SEER 1973–2013). Ocul Oncol Pathol. 4(3):145–151.
   PubMed Web of Science ®Google Scholar
• Athar M, Back JH, Kopelovich L, Bickers DR, Kim AL. 2009. Multiple molecular targets of resveratrol: anti-carcinogenic mechanisms. Arch Biochem Biophys. 486(2):95–102.
   PubMed Web of Science ®Google Scholar
• Back JH, Zhu Y, Calabro A, Queenan C, Kim AS, Arbesman J, Kim AL. 2012. Resveratrol-mediated downregulation of Rictor attenuates autophagic process and suppresses UV-induced skin carcinogenesis. Photochem Photobiol. 88(5):1165–1172.
   PubMed Web of Science ®Google Scholar
• Bartlett MS. 1950. Tests of significance in factor analysis. Br J Stat Psychol. 3(2):77–85.
   Web of Science ®Google Scholar
• Bauer NN, Chen YW, Samant RS, Shevde LA, Fodstad O. 2007. Rac1 activity regulates proliferation of aggressive metastatic melanoma. Exp Cell Res. 313(18):3832–3839.
   PubMed Web of Science ®Google Scholar
• Bennett RN, Wallsgrove RM. 1994. Secondary metabolites in plant defense mechanisms. New Phytol. 127(4):617–633.
   PubMed Web of Science ®Google Scholar
• Birch-Johansen F, Jensen A, Olesen AB, Christensen J, Tjønneland A, Kjaer SK. 2012. Does hormone replacement therapy and use of oral contraceptives increase the risk of non-melanoma skin cancer? Cancer Causes Control. 23(2):379–388.
   PubMed Web of Science ®Google Scholar
• China Statistical Yearbook. 2010. Beijing (China): China Statistics Press.
   Google Scholar
• Didsbury J, Weber RF, Bokoch GM, Evans T, Snyderman R. 1989. RAC, a novel RAS-related family of proteins that are botulinum toxin substrates. J Biol Chem. 264(28):16378–16382.
   PubMed Web of Science ®Google Scholar
• Doonan F, Cotter TG. 2008. Morphological assessment of apoptosis. Methods. 44(3):200–204.
   PubMed Web of Science ®Google Scholar
• Elmore S. 2007. Apoptosis: a review of programmed cell death. Toxicol Pathol. 35(4):495–516.
   PubMed Web of Science ®Google Scholar
• Fagerberg L, Hallström BM, Oksvold P, Kampf C, Djureinovic D, Odeberg J, Habuka M, Tahmasebpoor S, Danielsson A, Edlund K, et al. 2014. Analysis of the human tissue-specific expression by genome-wide integration of transcriptomics and antibody-based proteomics. Mol Cell Proteomics. 13(2):397–406.
   PubMed Web of Science ®Google Scholar
• Fesik SW. 2005. Promoting apoptosis as a strategy for cancer drug discovery. Nat Rev Cancer. 5(11):876.
   PubMed Web of Science ®Google Scholar
• Gatouillat G, Balasse E, Joseph-Pietras D, Morjani H, Madoulet C. 2010. Resveratrol induces cell-cycle disruption and apoptosis in chemoresistant B16 melanoma . J Cell Biochem. 110(4):893–902.
   PubMed Web of Science ®Google Scholar
• Goswami SK, Das DK. 2009. Resveratrol and chemoprevention. Cancer Lett. 284(1):1–6.
   PubMed Web of Science ®Google Scholar
• Hao Y, Huang WX, Feng H, Zhang GH, Ning XH, Li HG, Hao CG, Li ZH. 2013. Study of apoptosis related factors regulatory mechanism of resveratrol to human skin squamous cell carcinoma A431 xenograft in nude mice. Zhonghua yi Xue za Zhi. 93(6):464–468.
   PubMedGoogle Scholar
• He Y, Liu Z, Qiao C, Xu M, Yu J, Li G. 2014. Expression and significance of Wnt signaling components and their target genes in breast carcinoma. Mol Med Rep. 9(1):137–143.
   PubMed Web of Science ®Google Scholar
• Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M, Theurillat J-P, Nickerson E, Auclair D, Li L, Place C, et al. 2012. A landscape of driver mutations in melanoma. Cell. 150(2):251–263.
   PubMed Web of Science ®Google Scholar
• Hsieh TC, Wang Z, Hamby CV, Wu JM. 2005. Inhibition of melanoma cell proliferation by resveratrol is correlated with upregulation of quinone reductase 2 and p53. Biochem Biophys Res Commun. 334(1):223–230.
   PubMed Web of Science ®Google Scholar
• Hulpiau P, Van Roy F. 2009. Molecular evolution of the cadherin superfamily. Int J Biochem Cell Biol. 41(2):349–369.
   PubMed Web of Science ®Google Scholar
• Ishiyama M, Miyazono Y, Sasamoto K, Ohkura Y, Ueno K. 1997. A highly water-soluble disulfonated tetrazolium salt as a chromogenic indicator for NADH as well as cell viability. Talanta. 44(7):1299–1305.
   PubMed Web of Science ®Google Scholar
• Jasiński M, Jasińska L, Ogrodowczyk M. 2013. Resveratrol in prostate diseases – a short review. Central Eur J Urol. 66:144–149.
   PubMedGoogle Scholar
• Jiang Z, Chen K, Cheng L, Yan B, Qian W, Cao J, Li J, Wu E, Ma Q, Yang W. 2017. Resveratrol and cancer treatment: updates. Ann N Y Acad Sci. 1403(1):59–69.
   PubMed Web of Science ®Google Scholar
• Jordan P, Brazåo R, Boavida MG, Gespach C, Chastre E. 1999. Cloning of a novel human Rac1b splice variant with increased expression in colorectal tumors. Oncogene. 18(48):6835–6839.
   PubMed Web of Science ®Google Scholar
• Kim SM, Kim SZ. 2018. Biological activities of resveratrol against cancer. J. Phys Chem Biophys. 7:267.
   Google Scholar
• Krauthammer M, Kong Y, Ha BH, Evans P, Bacchiocchi A, McCusker JP, Cheng E, Davis MJ, Goh G, Choi M, et al. 2012. Exome sequencing identifies recurrent somatic RAC1 mutations in melanoma. Nat Genet. 44(9):1006–1014.
   PubMed Web of Science ®Google Scholar
• Li D, Zhang J, Zhang Y, Zhao PW, Yang LM. 2015. Inhibitory effect of berberine on human skin squamous cell carcinoma A431 cells. Genet Mol Res. 14(3):10553–10568.
   PubMed Web of Science ®Google Scholar
• Lv J, Zhu P, Zhang X, Zhang L, Chen X, Lu F, Yu Z, Liu S. 2017. PCDH9 acts as a tumor suppressor inducing tumor cell arrest at G0/G1 phase and is frequently methylated in hepatocellular carcinoma. Mol Med Report. 16(4):4475–4482.
   PubMed Web of Science ®Google Scholar
• MacLachlan TK, Sang N, Giordano A. 1995. Cyclins, cyclin-dependent kinases and cdk inhibitors: implications in cell cycle control and cancer. Crit Rev Eukaryot Gene Expr. 5(2):127–156.
   PubMed Web of Science ®Google Scholar
• McAllister SS. 2012. Got a light? Illuminating lung cancer. Sci Transl Med. 4(142):142fs22.
   PubMed Web of Science ®Google Scholar
• Niles RM, McFarland M, Weimer MB, Redkar A, Fu YM, Meadows GG. 2003. Resveratrol is a potent inducer of apoptosis in human melanoma cells. Cancer Lett. 190(2):157–163.
   PubMed Web of Science ®Google Scholar
• Ouyang YH. 2010. Skin cancer of the head and neck. Semin Plast Surg. 24(2):117–126.
   PubMedGoogle Scholar
• Pucci B, Kasten M, Giordano A. 2000. Cell cycle and apoptosis. Neoplasia. 2(4):291–299.
   PubMed Web of Science ®Google Scholar
• Sales JM, Resurreccion AV. 2014. Resveratrol in peanuts. Crit Rev Food Sci Nutr. 54(6):734–770.
   PubMed Web of Science ®Google Scholar
• Samarasinghe V, Madan V. 2012. Nonmelanoma skin cancer. J Cutan Aesthet Surg. 5(1):3–10.
   PubMedGoogle Scholar
• Shin JA, Shim JH, Jeon JG, Choi KH, Choi ES, Cho NP, Cho SD. 2011. Apoptotic effect of Polygonum cuspidatum in oral cancer cells through the regulation of specificity protein 1. Oral Dis. 17(2):162–170.
   PubMed Web of Science ®Google Scholar
• Team RC. 2013. A language and environment for statistical. http://www.R-project.org/.
   Google Scholar
• Tominaga H, Ishiyama M, Ohseto F, Sasamoto K, Hamamoto T, Suzuki K, Watanabe M. 1999. A water-soluble tetrazolium salt useful for colorimetric cell viability assay. Anal Commun. 36(2):47–50.
   Google Scholar
• Wickham H. 2016. ggplot2: elegant graphics for data analysis. NY (USA): Springer-Verlag.
   Google Scholar
• Wu Z, Liu BIN, E C, Liu JIE, Zhang Q, Liu J, Chen N, Chen R, Zhu R. 2015. Resveratrol inhibits the proliferation of human melanoma cells by inducing G1/S cell cycle arrest and apoptosis. Mol Med Rep. 11(1):400–404.
   PubMed Web of Science ®Google Scholar
• Yuan Y, Kwok RTK, Tang BZ, Liu B. 2014. Targeted theranostic platinum (IV) prodrug with a built-in aggregation-induced emission light-up apoptosis sensor for noninvasive early evaluation of its therapeutic responses in situ. J Am Chem Soc. 136(6):2546–2554.
   PubMed Web of Science ®Google Scholar